An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.
Peng Y. et al, (2022), Nat Immunol, 23, 50 - 61
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells
Cassioli C. et al, (2021), Frontiers in Cell and Developmental Biology, 9
RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line
Felce SL. et al, (2021), Wellcome Open Research, 5, 42 - 42
RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line
Felce SL. et al, (2020), Wellcome Open Research, 5, 42 - 42
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model.
Felce SL. et al, (2020), Front Oncol, 10
Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Christott T. et al, (2019), SLAS Discov, 24, 133 - 141
Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
Moustakim M. et al, (2018), Angew Chem Int Ed Engl, 57, 16302 - 16307
N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
Brown PJ. et al, (2016), Haematologica, 101, 861 - 871
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ. et al, (2016), Leukemia, 30, 605 - 616
Recombinant viral vaccines for cancer
Cawood R. et al, (2012), Trends in Molecular Medicine, 18, 564 - 574
MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
Cawood R. et al, (2011), PLoS One, 6